Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suvorexant for Smoking Relapse Risk
NCT04234997Phase 2Completed
- Sponsor
- UTHealth Houston
- Start
- Aug 2021
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of suvorexant in Tobacco Use Disorder (TUD), sponsored by UTHealth Houston. Started Aug 2021; status: completed.
02
Drugs
suvorexant
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT04234997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04234997.